The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 184 articles
Double chimney stenting without contrast during transcatheter aortic valve-in-valve implantation
August 25, 2022 | 10.4244/EIJ-D-22-00385
Pre-procedural Planning of Coronary Revascularization by Cardiac Computed Tomography: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography
Andreini D,
Collet C,
Leipsic J,
Nieman K,
Bittencurt M,
De Mey J,
Buls N,
Onuma Y,
Mushtaq S,
Conte E,
Bartorelli A,
Stefanini G,
Sonck J,
Knaapen P,
Ghoshhajra B,
Serruys P
August 22, 2022 | 10.4244/EIJ-E-22-00036
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter R,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits P,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
August 19, 2022 | 10.4244/EIJ-D-21-00766
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek JJ,
Garg S,
Hamm C,
Steg PG,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen J,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson T,
Pan M,
Chatzizisis Y,
Banning A,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone G,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys P,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial
van Geuns R,
Chun-Chin C,
McEntegart M,
Merkulov E,
Kretov E,
Lesiak M,
O’Kane P,
Hanratty C,
Bressollette E,
Silvestri M,
Wlodarczak A,
Barragan P,
Anderson R,
Protopopov A,
Peace A,
Menown I,
Rocchiccioli P,
Onuma Y,
Oldroyd K
April 22, 2022 | 10.4244/EIJ-D-21-00514
A comparison of risk prediction models for patients with acute coronary syndromes
March 18, 2022 | 10.4244/EIJ-D-21-00536
Reply: Composite endpoints in clinical trials - simplicity or perfection?
January 28, 2022 | 10.4244/EIJ-D-21-00440R
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials
Azzalini L,
Ellis S,
Kereiakes D,
Kimura T,
Gao R,
Onuma Y,
Chevalier B,
Dressler O,
Crowley A,
Zhou Z,
Redfors B,
Serruys P,
Stone G
December 17, 2021 | 10.4244/EIJ-D-21-00263
Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial
Faria D,
Lee JM,
van de Hoef T,
Mejía-Rentería H,
Echavarria-Pinto M,
Baptista S,
Cerrato E,
Garcia-Garcia H,
Davies J,
Onuma Y,
Samady H,
Piek JJ,
Serruys P,
Lerman A,
Escaned J
October 20, 2021 | 10.4244/EIJ-D-20-01163
Statistical methods for composite endpoints
Hara H,
van Klaveren D,
Kogame N,
Chichareon P,
Modolo R,
Tomaniak M,
Ono M,
Kawashima H,
Takahashi K,
Capodanno D,
Onuma Y,
Serruys P
April 2, 2021 | 10.4244/EIJ-D-19-00953
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
Miyazaki Y,
Muramatsu T,
Asano T,
Katagiri Y,
Sotomi Y,
Nakatani S,
Takahashi K,
Kogame N,
Higuchi Y,
Ishikawa M,
Kyono H,
Yano M,
Ozaki Y,
Serruys P,
Okamura T,
Onuma Y
March 19, 2021 | 10.4244/EIJ-D-18-00902
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K,
Takahashi K,
Asano T,
Katagiri Y,
Hochul M,
Buszman P,
Tomaniak M,
Gorycki B,
Zurakowski A,
Janas A,
Mlodziankowski A,
Kachel M,
Wykrzykowska JJ,
Wijns W,
de Winter R,
Buszman P,
Onuma Y,
Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Coronary interventions in 2020: the year in review
February 5, 2021 | 10.4244/EIJ-D-20-01343
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Hara H,
Gao C,
Kogame N,
Ono M,
Kawashima H,
Wang R,
Morel M,
O'Leary N,
Sharif F,
Möllmann H,
Reiber J,
Sabaté M,
Zaman A,
Wijns W,
Onuma Y,
Serruys P
December 18, 2020 | 10.4244/EIJ-D-20-00772
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Latest news
AHEAD OF PRINT
COMBINE OCT–FFR study extended follow-up
FREE ARTICLE - Enrico Fabris et al
September 28, 2022
NEW ISSUE
A state-of-the-art on CTO recanalisation; timing of coronary angiography in NSTE-ACS; an expert consensus on the use of IVUS in peripheral interventions, and more
September 20, 2022
AHEAD OF PRINT
The UZ Clear study
FREE ARTICLE - Bert Vandeloo et al
September 23, 2022
AHEAD OF PRINT
Subanalysis of SCOPE 2 – pacemaker and LBBB
FREE ARTICLE - Costanza Pellegrini et al
September 21, 2022
AHEAD OF PRINT TCT
Early Alirocumab treatment in STEMI
FREE ARTICLE - Shamir R. Mehta et al
September 19, 2022
AHEAD OF PRINT TCT
Timing of Bioprosthetic valve fracture in transcatheter valvein- valve intervention: impact on valve durability and leaflet integrity
FREE ARTICLE - David Meier et al
September 18, 2022
AHEAD OF PRINT TCT
Acute Outcomes for the Full US Cohort of the FLASH Mechanical Thrombectomy Registry in Pulmonary Embolism
FREE ARTICLE - Catalin Toma et al
September 18, 2022